|
Munoz-Garrido, Patricia; Marin, José J G; Perugorria, María J et al. (2015) Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease. J Hepatol 63:952-61
|
|
Masyuk, Anatoliy I; Masyuk, Tatyana V; Larusso, Nicholas F (2013) Exosomes in the pathogenesis, diagnostics and therapeutics of liver diseases. J Hepatol 59:621-5
|
|
Masyuk, Anatoliy I; Huang, Bing Q; Radtke, Brynn N et al. (2013) Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling. Am J Physiol Gastrointest Liver Physiol 304:G1013-24
|
|
Tietz Bogert, Pamela S; Huang, Bing Q; Gradilone, Sergio A et al. (2013) The zebrafish as a model to study polycystic liver disease. Zebrafish 10:211-7
|
|
Masyuk, Tatyana V; Radtke, Brynn N; Stroope, Angela J et al. (2013) Pasireotide is more effective than octreotide in reducing hepatorenal cystogenesis in rodents with polycystic kidney and liver diseases. Hepatology 58:409-21
|
|
O'Hara, Steven P; Tabibian, James H; Splinter, Patrick L et al. (2013) The dynamic biliary epithelia: molecules, pathways, and disease. J Hepatol 58:575-82
|
|
Banales, Jesús M; Sáez, Elena; Uriz, Miriam et al. (2012) Up-regulation of microRNA 506 leads to decreased Cl-/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 56:687-97
|
|
Masyuk, Tatyana V; Radtke, Brynn N; Stroope, Angela J et al. (2012) Inhibition of Cdc25A suppresses hepato-renal cystogenesis in rodent models of polycystic kidney and liver disease. Gastroenterology 142:622-633.e4
|
|
Larusso, Nicholas F (2011) Patients, cells, and organelles: the intersection of science and serendipity. Hepatology 53:1417-26
|
|
Huebert, Robert C; Jagavelu, Kumaravelu; Hendrickson, Helen I et al. (2011) Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs. Am J Pathol 179:1851-60
|
Showing the most recent 10 out of 135 publications
